Free Trial
→ $0. Later: $29.97. (From Profits Run) (Ad)tc pixel Free TEVA Stock Alerts

Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts

Teva Pharmaceutical Industries logo
$43.71 +0.06 (+0.15%)
As of 12:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Teva Pharmaceutical Industries Earnings Summary

Teva Pharmaceutical Industries posted Q3 2026 earnings on November 3, 2026, reporting an EPS of $0.86, which topped analysts' consensus estimates of $0.72 by $0.14. Quarterly revenue fell 1.9% year-over-year to $4.40 billion, above analyst estimates of $4.23 billion. With a trailing EPS of $0.43 and a P/E Ratio of 101.29, Teva Pharmaceutical Industries' earnings are expected to grow 55.56% next year, from $1.98 to $3.08 per share.

Upcoming Q4
Earnings Date
Jan. 27Before Market OpensEstimated
Consensus EPS
(Nov. 3)
$0.72
Actual EPS
(Nov. 3)
$0.86 Beat By $0.14
Actual Revenue
(Nov. 3)
$4.40B

Q3 2026 Earnings Resources

TEVA Upcoming Earnings

Teva Pharmaceutical Industries' next earnings date is estimated for Wednesday, January 27, 2027, based on past reporting schedules.

Slide Deck

Teva Pharmaceutical Industries' Q3 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get Teva Pharmaceutical Industries Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teva Pharmaceutical Industries and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TEVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TEVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Teva Pharmaceutical Industries Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS GuidanceCompany Revenue GuidanceRevenue Estimate at Guidance
Q1 20261$0.51$0.51$0.51
Q2 20261$0.61$0.61$0.61
Q3 20262$0.69$0.71$0.70
Q4 20262$0.64$0.77$0.71
FY 20266$2.45$2.60$2.53
Q1 20272$0.63$0.65$0.64
Q2 20272$0.70$0.74$0.72
Q3 20272$0.79$0.83$0.81
Q4 20271$0.91$0.91$0.91
FY 20277$3.03$3.13$3.08

Teva Pharmaceutical Industries Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
1/27/2027
(Estimated)		--------
11/3/2026Q3 2026$0.72$0.86+$0.14$0.20$4.23B$4.40B
7/29/2026Q2 2026$0.08$0.02 -$0.06-$0.49$4.02B$4.14B
6/30/2026Q2 2026-$0.02--$0.49-$4.14B
4/29/2026Q1 2026$0.50$0.53+$0.03$0.31$3.79B$3.98B
3/31/2026Q1 2026-$0.53-$0.31-$3.98B
1/28/2026Q4 2025$0.65$0.96+$0.31$0.41$4.36B$4.71B
7/30/2025Q2 2025$0.64$0.66+$0.02$0.24$4.34B$4.18B
5/7/2025Q1 2025$0.47$0.52+$0.05$0.18$3.99B$3.89B
1/29/2025Q4 2024$0.69$0.70+$0.01-$0.19$4.10B-

Teva Pharmaceutical Industries Earnings - Frequently Asked Questions

Teva Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 27th, 2027 based off last year's report dates. Learn more on TEVA's earnings history.

In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.86 earnings per share (EPS) to beat the analysts' consensus estimate of $0.72 by $0.14. Learn more on analysts' earnings estimate vs. TEVA's actual earnings.

The conference call for Teva Pharmaceutical Industries' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Teva Pharmaceutical Industries' latest earnings report can be read online.
Read Transcript

Teva Pharmaceutical Industries' earnings report can be found in their filing with the SEC.
View SEC filing

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $17.26 billion.

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of $1.41 billion. TEVA has generated $0.43 earnings per share over the last four quarters.

Teva Pharmaceutical Industries (NYSE:TEVA) has a trailing price-to-earnings ratio of 101.22 and a forward price-to-earnings ratio of 14.13. The price/earnings-to-growth ratio is 4.05.

Teva Pharmaceutical Industries' earnings are expected to grow from $1.98 per share to $3.08 per share in the next year, which is a 55.56% increase.

Related Companies
Earnings Tools

Earnings data for NYSE:TEVA is sourced from Fiscal.ai, with the most recent quarter reported on 11/3/2026. New results are added as companies report their earnings.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel